Role of connexins in neurodegenerative diseases (Review)
- PMID: 33760195
- DOI: 10.3892/mmr.2021.12034
Role of connexins in neurodegenerative diseases (Review)
Abstract
Neurodegenerative diseases are neurological disorders characterized by progressive neuronal degeneration, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis and Huntington's disease. The neuronal damage caused by these diseases may be associated with abnormal alterations of connexins in glia. These changes may cause glia to lose their ability to support and protect neurons and induce abnormal increases in levels of ions and metabolites, such as calcium ions, glutamate and ATP, around neurons. These processes eventuallys lead to neuronal death. In the present review, the abnormal expression of connexin and its primary role in neurodegenerative diseases was investigated.
Keywords: connexin; neurodegenerative disease; PD; AD; ALS; HD.
Similar articles
-
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.Int J Mol Sci. 2020 Sep 28;21(19):7174. doi: 10.3390/ijms21197174. Int J Mol Sci. 2020. PMID: 32998479 Free PMC article. Review.
-
Mitochondria and neurodegeneration.Biosci Rep. 2007 Jun;27(1-3):87-104. doi: 10.1007/s10540-007-9038-z. Biosci Rep. 2007. PMID: 17486441 Review.
-
Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.Cells. 2020 Dec 8;9(12):2642. doi: 10.3390/cells9122642. Cells. 2020. PMID: 33302607 Free PMC article.
-
Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.Int J Mol Sci. 2019 Nov 30;20(23):6055. doi: 10.3390/ijms20236055. Int J Mol Sci. 2019. PMID: 31801298 Free PMC article. Review.
-
Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.Biofactors. 2024 May-Jun;50(3):422-438. doi: 10.1002/biof.2017. Epub 2023 Nov 15. Biofactors. 2024. PMID: 37966813 Review.
Cited by
-
Pharmacological effects of Astragalus polysaccharides in treating neurodegenerative diseases.Front Pharmacol. 2024 Aug 2;15:1449101. doi: 10.3389/fphar.2024.1449101. eCollection 2024. Front Pharmacol. 2024. PMID: 39156112 Free PMC article. Review.
-
CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer's and Parkinson's Disease.ACS Omega. 2021 Dec 16;6(51):35780-35798. doi: 10.1021/acsomega.1c05827. eCollection 2021 Dec 28. ACS Omega. 2021. PMID: 34984308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous